OrthoPediatrics Corp. Files 8-K

Ticker: KIDS · Form: 8-K · Filed: Mar 11, 2024 · CIK: 1425450

Orthopediatrics Corp 8-K Filing Summary
FieldDetail
CompanyOrthopediatrics Corp (KIDS)
Form Type8-K
Filed DateMar 11, 2024
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.00025
Sentimentneutral

Sentiment: neutral

Topics: disclosure, sec-filing

Related Tickers: KIDS

TL;DR

OrthoPediatrics filed a routine 8-K, no major news.

AI Summary

OrthoPediatrics Corp. filed an 8-K on March 11, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or material events beyond the standard reporting requirements for this form type.

Why It Matters

This 8-K filing indicates OrthoPediatrics Corp. is making a required disclosure to the SEC, which is standard for publicly traded companies.

Risk Assessment

Risk Level: low — This filing is a standard 8-K for disclosures and exhibits, not indicating any specific new risks or material events.

Key Players & Entities

  • ORTHOPEDIATRICS CORP (company) — Registrant
  • KIDS (company) — Trading Symbol
  • Nasdaq Global Market (company) — Exchange

FAQ

What is the primary purpose of this 8-K filing?

This 8-K filing serves as a Current Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, primarily for Regulation FD Disclosure and to report Financial Statements and Exhibits.

What is the trading symbol for OrthoPediatrics Corp. common stock?

The trading symbol for OrthoPediatrics Corp. common stock is KIDS.

On which exchange is OrthoPediatrics Corp. common stock traded?

OrthoPediatrics Corp. common stock is traded on the Nasdaq Global Market.

What is the principal executive office address for OrthoPediatrics Corp.?

The address of the principal executive offices is 2850 Frontier Drive, Warsaw, Indiana 46582.

What is the fiscal year end for OrthoPediatrics Corp.?

The fiscal year end for OrthoPediatrics Corp. is December 31.

Filing Stats: 505 words · 2 min read · ~2 pages · Grade level 10.3 · Accepted 2024-03-11 07:08:54

Key Financial Figures

  • $0.00025 — ange on which registered Common Stock, $0.00025 par value per share KIDS Nasdaq Global

Filing Documents

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. The executive officers of OrthoPediatrics Corp. have several upcoming presentations to representatives of investors and analysts. The officers intend to use the material filed as Exhibit 99.2 herewith, in whole or in part, as part of those presentations. The information in this Item 7.01, including the information incorporated by reference herein from Exhibit 99.2, is furnished pursuant to Item 7.01 of Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Orthopediatrics Corp. Investor Presentation dated March 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). * * * * * * SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. OrthoPediatrics Corp. Date: March 11, 2024 By: /s/ Daniel J. Gerritzen Daniel J. Gerritzen, General Counsel and Secretary - 2 -

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.